135 related articles for article (PubMed ID: 8840112)
1. Analysis of alternative splicing patterns in the cystic fibrosis transmembrane conductance regulator gene using mRNA derived from lymphoblastoid cells of cystic fibrosis patients.
Bienvenu T; Beldjord C; Chelly J; Fonknechten N; Hubert D; Dusser D; Kaplan JC
Eur J Hum Genet; 1996; 4(3):127-34. PubMed ID: 8840112
[TBL] [Abstract][Full Text] [Related]
2. Exon 9 of the CFTR gene: splice site haplotypes and cystic fibrosis mutations.
Dörk T; Fislage R; Neumann T; Wulf B; Tümmler B
Hum Genet; 1994 Jan; 93(1):67-73. PubMed ID: 7505767
[TBL] [Abstract][Full Text] [Related]
3. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA.
Chu CS; Trapnell BC; Curristin S; Cutting GR; Crystal RG
Nat Genet; 1993 Feb; 3(2):151-6. PubMed ID: 7684646
[TBL] [Abstract][Full Text] [Related]
4. Exon skipping through the creation of a putative exonic splicing silencer as a consequence of the cystic fibrosis mutation R553X.
Aznarez I; Zielenski J; Rommens JM; Blencowe BJ; Tsui LC
J Med Genet; 2007 May; 44(5):341-6. PubMed ID: 17475917
[TBL] [Abstract][Full Text] [Related]
5. Transcript analysis of CFTR frameshift mutations in lymphocytes using the reverse transcription-polymerase chain reaction technique and the protein truncation test.
Romey MC; Tuffery S; Desgeorges M; Bienvenu T; Demaille J; Claustres M
Hum Genet; 1996 Sep; 98(3):328-32. PubMed ID: 8707304
[TBL] [Abstract][Full Text] [Related]
6. Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis.
Hamosh A; Trapnell BC; Zeitlin PL; Montrose-Rafizadeh C; Rosenstein BJ; Crystal RG; Cutting GR
J Clin Invest; 1991 Dec; 88(6):1880-5. PubMed ID: 1721624
[TBL] [Abstract][Full Text] [Related]
7. A novel exon in the cystic fibrosis transmembrane conductance regulator gene activated by the nonsense mutation E92X in airway epithelial cells of patients with cystic fibrosis.
Will K; Dörk T; Stuhrmann M; Meitinger T; Bertele-Harms R; Tümmler B; Schmidtke J
J Clin Invest; 1994 Apr; 93(4):1852-9. PubMed ID: 7512993
[TBL] [Abstract][Full Text] [Related]
8. Fine characterization of the recurrent c.1584+18672A>G deep-intronic mutation in the cystic fibrosis transmembrane conductance regulator gene.
Costantino L; Rusconi D; Soldà G; Seia M; Paracchini V; Porcaro L; Asselta R; Colombo C; Duga S
Am J Respir Cell Mol Biol; 2013 May; 48(5):619-25. PubMed ID: 23349053
[TBL] [Abstract][Full Text] [Related]
9. Expression of an abundant alternatively spliced form of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is not associated with a cAMP-activated chloride conductance.
Strong TV; Wilkinson DJ; Mansoura MK; Devor DC; Henze K; Yang Y; Wilson JM; Cohn JA; Dawson DC; Frizzell RA
Hum Mol Genet; 1993 Mar; 2(3):225-30. PubMed ID: 7684641
[TBL] [Abstract][Full Text] [Related]
10. Transcript analysis of CFTR nonsense mutations in lymphocytes and nasal epithelial cells from cystic fibrosis patients.
Will K; Dörk T; Stuhrmann M; von der Hardt H; Ellemunter H; Tümmler B; Schmidtke J
Hum Mutat; 1995; 5(3):210-20. PubMed ID: 7541274
[TBL] [Abstract][Full Text] [Related]
11. Analysis of mutations and alternative splicing patterns in the CFTR gene using mRNA derived from nasal epithelial cells.
Hull J; Shackleton S; Harris A
Hum Mol Genet; 1994 Jul; 3(7):1141-6. PubMed ID: 7526925
[TBL] [Abstract][Full Text] [Related]
12. Quantitative expression patterns of multidrug-resistance P-glycoprotein (MDR1) and differentially spliced cystic-fibrosis transmembrane-conductance regulator mRNA transcripts in human epithelia.
Bremer S; Hoof T; Wilke M; Busche R; Scholte B; Riordan JR; Maass G; Tümmler B
Eur J Biochem; 1992 May; 206(1):137-49. PubMed ID: 1375156
[TBL] [Abstract][Full Text] [Related]
13. Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene.
Aznarez I; Chan EM; Zielenski J; Blencowe BJ; Tsui LC
Hum Mol Genet; 2003 Aug; 12(16):2031-40. PubMed ID: 12913074
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing in the first nucleotide binding fold of CFTR.
Will K; Stuhrmann M; Dean M; Schmidtke J
Hum Mol Genet; 1993 Mar; 2(3):231-5. PubMed ID: 7684642
[TBL] [Abstract][Full Text] [Related]
15. Similar levels of mRNA from the W1282X and the delta F508 cystic fibrosis alleles, in nasal epithelial cells.
Shoshani T; Kerem E; Szeinberg A; Augarten A; Yahav Y; Cohen D; Rivlin J; Tal A; Kerem B
J Clin Invest; 1994 Apr; 93(4):1502-7. PubMed ID: 7512981
[TBL] [Abstract][Full Text] [Related]
16. Exon-skipping antisense oligonucleotides for cystic fibrosis therapy.
Kim YJ; Sivetz N; Layne J; Voss DM; Yang L; Zhang Q; Krainer AR
Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35017301
[TBL] [Abstract][Full Text] [Related]
17. The relationship between genotype and phenotype in cystic fibrosis.
Kerem E; Kerem B
Curr Opin Pulm Med; 1995 Nov; 1(6):450-6. PubMed ID: 9363081
[TBL] [Abstract][Full Text] [Related]
18. A donor splice mutation (405 + 1 G-->A) in cystic fibrosis associated with exon skipping in epithelial CFTR mRNA.
Dörk T; Will K; Demmer A; Tümmler B
Hum Mol Genet; 1993 Nov; 2(11):1965-6. PubMed ID: 7506605
[No Abstract] [Full Text] [Related]
19. Nonsense mutation R1162X of the cystic fibrosis transmembrane conductance regulator gene does not reduce messenger RNA expression in nasal epithelial tissue.
Rolfini R; Cabrini G
J Clin Invest; 1993 Dec; 92(6):2683-7. PubMed ID: 7504691
[TBL] [Abstract][Full Text] [Related]
20. Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A-->G, 2751+2T-->A, 296+1G-->C, 1717-9T-->C-D565G) and one nonsense mutation (E822X) in the CFTR gene.
Tzetis M; Efthymiadou A; Doudounakis S; Kanavakis E
Hum Genet; 2001 Dec; 109(6):592-601. PubMed ID: 11810271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
